- IP hearings this week
- IP trials
- IP Judicial review hearings
- IP appeals at the Federal Court of Appeal
(As published on the Federal Court and Federal Court of Appeal websites on Feb 18, 2020 at 00:00:00)
This week in IP
| Date | File No. | Type | Name | Location | Length |
| Feb 18, 2020 | T-926-19 | JR | Pentastar Transportation Ltd V. Fca Us Llc (Trade Mark - JR) | Ottawa | 4 h |
| Feb 18, 2020 | T-7-20 | CMC | Amgen Inc Et Al V. Pfizer Canada Ulc (Patent - Pegfilgrastim*) | Toronto | 30 m |
| Feb 18, 2020 | T-396-13 | CMC | Hospira Healthcare Corporation V. The Kennedy Institute Of Rheumatology (Patent - Infliximab*) | Toronto | 30 m |
| Feb 19, 2020 | T-1795-19 | CMC | Pfizer Canada Ulc Et Al V. Sandoz Canada Inc. (Patent - Sunitinib*) | Toronto | 30 m |
| Feb 19, 2020 | T-53-20 | CMC | Pfizer Canada Ulc Et Al V. Sandoz Canada Inc (Patent - Sunitinib*) | Toronto | 30 m |
| Feb 20, 2020 | T-1069-14 | TMC | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Ottawa | 1 h |
| Feb 20, 2020 | T-1479-19 | CMC | Ecore International Inc V Pliteq Inc. (Patent) | Ottawa | 1 h |
| Feb 21, 2020 | T-1163-18 | TMC | Biogen Canada Inc Et Al V. Taro Pharmaceuticals Inc (Patent - Fampridine*) | Toronto | 1 h |
| Feb 21, 2020 | T-220-19 | TMC | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Toronto | 1 h |
| Feb 21, 2020 | T-1527-18 | TMC | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Ottawa | 2 h |
| Feb 21, 2020 | T-1529-18 | TMC | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Ottawa | 2 h |
| Feb 24, 2020 | A-355-18 | APP | Her Majesty The Queen In Right Of Ontario V. Quality Program Services Inc. (Trade-mark) | Toronto | 4 h |
| Feb 24, 2020 | T-1842-16 | MED | Dsd International Inc Et Al C. Dominion & Grimm Inc. (Patent) | Montréal | 1 d |
Return to top.
Scheduled IP Trials
| Date | File No. | Name | Location | Length |
| Feb 3, 2020 | T-353-18 | Janssen Inc. Et Al V. Teva Canada Limited (Patent - Paliperidone*) | Toronto | 15 d |
| Feb 3, 2020 | T-546-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Et Al (Patent) | Montréal | 25 d |
| Mar 2, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Toronto | 10 d |
| Mar 2, 2020 | T-1163-18 | Biogen Canada Inc Et Al V. Taro Pharmaceuticals Inc (Patent - Fampridine*) | Toronto | 10 d |
| Mar 9, 2020 | T-921-17 | Rovi Guides, Inc. Et Al V. Videotron Ltd. (Patent) | Toronto | 20 d |
| Mar 23, 2020 | T-168-18 | Lickerish, Ltd. V. Airg Inc. (Copyright) | Calgary | 5 d |
| Mar 30, 2020 | T-1529-18 | Celgene Inc. Et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Mar 30, 2020 | T-1527-18 | Celgene Inc.et Al V. Natco Pharma Inc. (Patent - Lenalidomide*) | Toronto | 10 d |
| Apr 20, 2020 | T-1069-14 | Jason Swist Et Al V. Meg Energy Corp. (Patent) | Toronto | 10 d |
| May 4, 2020 | T-569-17 | J.r. Simplot Company V. Mccain Foods Ltd. V. Simplot Canada (ii) Limited (Trade Mark) | Ottawa | 7 d |
| May 4, 2020 | T-1842-16 | Dsd International Inc Et Al C. Dominion & Grimm Inc. (Patent) | Montréal | 7 d |
| May 11, 2020 | T-311-12 | Bauer Hockey Ltd. V. Sport Maska Inc. Dba Reebok-ccm Hockey (Trade Mark) | Montréal | 13 d |
| May 13, 2020 | T-133-18 | Alexander Stross V. Polly Reitze Personal Real Estate Corporation, Et Al. (Copyright) | Calgary | 1 d |
| May 25, 2020 | T-206-18 | Rovi Guides, Inc. Et Al V. Telus Corporation Et Al (Patent) | Toronto | 20 d |
| May 25, 2020 | T-113-18 | Rovi Guides Inc Et Al V. Bce Inc. Et Al (Patent) | Toronto | 20 d |
| Jun 1, 2020 | T-449-17 | Farmobile, Llc. V. Farmers Edge Inc. (Patent) | Winnipeg | 12 d |
| Jun 1, 2020 | T-448-17 | Guest Tek Interactive Entertainment Ltd. V. Nomadix, Inc. (Patent) | Calgary | 14 d |
| Jun 15, 2020 | T-2023-18 | Allergan Inc. V. Sandoz Canada Inc. Et Al (Patent - Silodosin*) | Toronto | 10 d |
| Jul 15, 2020 | T-220-19 | Biogen Canada Inc. Et Al. V. Pharmascience Inc. (Patent - Fampridine*) | Ottawa | 3 d |
| Aug 24, 2020 | T-2183-18 | Teva Canada Innovation And Others V. Pharmascience Inc. And Others (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 24, 2020 | T-2182-18 | Teva Canada Innovation Et Al. V. Pharmascience Et Al. (Patent - Glatiramer*) | Toronto | 10 d |
| Aug 31, 2020 | T-913-17 | Canadian National Railway Company V. Bnsf Railway Company Et Al. (Patent) | Toronto | 14 d |
| Sep 1, 2020 | T-806-19 | Bayer Inc Et Al. V. Sandoz Canada Inc. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-435-19 | Bayer Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Toronto | 11 d |
| Sep 1, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Toronto | 11 d |
| Sep 14, 2020 | T-205-19 | Triteq Lock & Security, Llc V. Minus Forty Technologies Corp. (Patent) | Toronto | 5 d |
| Sep 14, 2020 | T-504-19 | Bristol-myers Squibb Canada Co. El Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-503-19 | Bristol-myers Squibb Canada Co. Et Al V. Sandoz Canada Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-98-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience Inc. (Patent - Apixaban*) | Toronto | 17 d |
| Sep 14, 2020 | T-97-19 | Bristol-myers Squibb Canada Co. Et Al V. Pharmascience (Patent - Apixaban*) | Toronto | 17 d |
| Sep 17, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Toronto | 2 d |
| Sep 21, 2020 | T-1960-18 | Bayer Inc. And Bayer Intellectual Property Gmbh V. Teva Canada Lmt. (Patent - Rivaroxaban*) | Ottawa | 2 d |
| Oct 13, 2020 | T-902-19 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 8 d |
| Oct 13, 2020 | T-954-18 | Deeproot Green Infrastructure, Llc Et Al V. Greenblue Urban North America In (Patent) | Toronto | 13 d |
| Oct 13, 2020 | T-2093-18 | Bayer Inc. Et Al V. Apotex Inc. (Trade Mark - Rivaroxaban*) | Toronto | 2 d |
| Oct 19, 2020 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Oct 26, 2020 | T-1893-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-978-19 | Janssen Inc. Et Al V. Dr. Reddy's Laboratories Ltd. Et Al (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-182-19 | Janssen Inc. Et Al. V. Pharmascience Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Oct 26, 2020 | T-84-19 | Janssen Inc. Et Al. V. Apotex Inc. (Patent - Abiraterone*) | Toronto | 20 d |
| Nov 9, 2020 | T-902-19 | Amgen Inc. Et Al. V. Sandoz Canada Inc. (Patent - Pegfilgrastim*) | Toronto | 2 d |
| Nov 16, 2020 | T-630-18 | Maoz Betser-zilevitch V. Canadian Natural Resources Ltd. (Patent) | Toronto | 10 d |
| Nov 16, 2020 | T-227-17 | Dtechs Epm Ltd. V. British Columbia Hydro And Power Authority Et Al. (Patent) | Vancouver | 10 d |
| Nov 23, 2020 | T-917-17 | Sse Holdings, Llc Et Al V. Le Chic Shack Inc. (Trade Mark) | Québec | 5 d |
| Nov 30, 2020 | T-1158-18 | Maoz Betser-zilevitch V. Petrochina Canada Ltd. (Patent) | Toronto | 12 d |
| Nov 30, 2020 | T-1184-17 | Merck Sharp & Dohme Corp.et Al V. Wyeth Llc (Patent - Pneumococcal*) | Toronto | 10 d |
| Jan 11, 2021 | T-435-19 | Bayer Inc. Et Al V. Taro Pharmaceuticals Inc. (Patent - Rivaroxaban*) | Ottawa | 5 d |
| Jan 11, 2021 | T-708-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-706-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - PIRFENIDONE*) | Toronto | 10 d |
| Jan 11, 2021 | T-705-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 11, 2021 | T-704-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 10 d |
| Jan 18, 2021 | T-151-16 | Angelcare Development Inc. Et Al. V. Munchkin, Inc Et Al. (Patent) | Montréal | 40 d |
| Feb 1, 2021 | T-806-19 | Bayer Inc Et Al. V. Sandoz Canada Inc. (Patent - Rivaroxaban*) | Ottawa | 5 d |
| Feb 1, 2021 | T-794-19 | Allergan Inc. Et Al V. Apotex Inc. (Patent - Risedronate*) | Toronto | 10 d |
| Feb 1, 2021 | T-1434-14 | Pharmascience Inc. V. Pfizer Canada Ulc (PMNOC - Section 8 - Pregabalin*) | Toronto | 30 d |
| Feb 8, 2021 | T-1004-18 | Akebia Therapeutics, Inc. V. Fibrogen, Inc. (Patent) | Toronto | 12 d |
| Feb 15, 2021 | T-1008-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-1007-19 | Hoffmann-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-943-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-942-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-941-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-939-19 | Hoffman-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-899-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-898-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-897-19 | Hoffmann-la Roche Limited Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-896-19 | Hoffman-la Roche Limited Et Al. V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-770-19 | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
| Feb 15, 2021 | T-768-19 | Hoffmann-la Roche Ltd. Et Al V. Sandoz Canada Inc. (Patent - Pirfenidone*) | Toronto | 15 d |
Return to top.
Scheduled Judicial Review Hearings
| Date | File No. | Name | Type | Location | Length |
| Feb 18, 2020 | T-926-19 | Pentastar Transportation Ltd V. Fca Us Llc | Trade Mark Opposition | Ottawa | 4 h |
| Mar 2, 2020 | T-1564-19 | Inguran Llc Dba Stgenetics V. Commissioner Of The Patents | Patent - Correction of Register | Ottawa | 2 h |
| Mar 30, 2020 | T-1944-18 | Brandstorm, Inc. V. Naturally Splendid Enterprises Ltd. | Trade Mark Opposition | Vancouver | 3 h |
| Apr 2, 2020 | T-1045-19 | Edmond Chiu V. Minister Of Health | S. 18.1 Application for Judicial Review | Vancouver | 1 d |
| Apr 27, 2020 | T-1465-19 | Innovative Medicines Canada Et Al V. Agc | S. 18.1 Application for Judicial Review | Toronto | 2 d |
| May 11, 2020 | T-1148-19 | 387191 Alberta Ltd. And Holy Grill Inc. V. Chef Aleem Inc. | Trade Mark Expungement | Calgary | 1 h |
| May 11, 2020 | T-1400-19 | Sim & Mcburney V. Gayle Gordon | S. 18.1 Application for Judicial Review | Toronto | 1 d |
| May 12, 2020 | T-1353-19 | Natco Pharma (canada) Inc. V. Min Health & Agc & Gilead Sciences Canada Inc. - Emtricitabine* | S. 18.1 Application for Judicial Review | Toronto | 3 h |
| May 27, 2020 | T-1813-19 | Alfasigma S.p.a. V. Attorney General Of Canada Et Al - Rifaximin* | Statutory Appeal (code not provided elsewhere) | Toronto | 1 h |
Return to top.
Scheduled IP Appeals
| Date | File No. | Name | Type | Location | Length |
| Feb 24, 2020 | A-355-18 | Her Majesty The Queen In Right Of Ontario V. Quality Program Services Inc. | Appeal (S.27 - Final) - Trade-marks Act [from T-1787-16 - Trade Mark Infringement] | Toronto | 4 h |
| Feb 25, 2020 | A-405-19 | Pfizer Canada Ulc V. Pharmascience Inc. - Pregabalin* | Appeal (S.27 - Interloc.) - Others [from T-1434-14 - PMNOC - Section 8] | Toronto | 3 h |
| Mar 18, 2020 | A-325-18 | Miller Thomson Llp V. Hilton Worldwide Holding Llp | Appeal (S.27 - Final) - Trade-marks Act [from T-515-17 - Trade Mark Expungement] | Ottawa | 3 h |
| Mar 18, 2020 | A-369-18 | Miller Thomson Llp V. Hilton Worldwide Holding Llp | Appeal (S.27 - Interloc.) - Trade-marks Act [from T-515-17 - Trade Mark Expungement] | Ottawa | 3 h |
| Mar 23, 2020 | A-121-19 | Bedessee Imports Ltd. V. Glaxosmithkline Consumer Healthcare (uk) Ip | Appeal (S.27 - Final) - Trade-marks Act [from T-1746-17 - Trade Mark Expungement] | Toronto | 3 h |
| Mar 24, 2020 | A-15-20 | Teva Canada Limited V. Bayer Inc Et Al. - Xarelto* | Appeal (S.27 - Interloc.) - Patent Act | Toronto | 3 h |
| Mar 24, 2020 | A-16-20 | Apotex Inc. V Bayer Inc.et Al - Rivaroxaban* | Appeal (S.27 - Interloc.) - Patent Act | Toronto | 3 h |
* Medicinal ingredients are based on automated analysis and should not be relied upon.
Return to top.